Risk assessment of new psychoactive substances - EMCDDA - Europa

More documents

Recommendations

Info

ContentsAcknowledgements 5Foreword 7Introduction 11Chapter 1: Legal basis and scope 15Chapter 2: General considerations for risk assessment 21Chapter 3: A conceptual framework for risk assessment 27Chapter 4: Headings for the Risk Assessment Report 33Chapter 5: Assessing the risks relative to other substances 43Chapter 6: Conclusion 45References 47Annex I: Technical report 49Annex II: Semi-quantitative assessment procedure 57Annex III: Expert’s scoring form 63Appendix: Council Decision 2005/387/JHA 75
Page 7: EMCDDA project leaders: Dr Roumen S
Page 14: Risk assessment of new psychoactive
Page 18 and 19: Risk assessment of new psychoactive
Page 45: Chapter 5Assessing the risks relati
Page 49: ReferencesNutt, D., King, L., Sauls
Page 52 and 53:
Risk assessment of new psychoactive
Page 54 and 55:
Page 56:
Page 60 and 61:
Page 62 and 63:
Page 65 and 66:
Annex IIIExpert’s scoring formNam
Page 67 and 68:
Domain B: Dependence and abuse pote
Page 69 and 70:
Domain D: Health risksD1. Acute hea
Page 71 and 72:
E4. Economic costsRL: 0 1 2 3 4 nEx
Page 73 and 74:
F4. Impact of violence from crimina
Page 77 and 78:
AppendixCouncil Decision 2005/387/J
Page 79 and 80:
Decision. Suitable regulatory and p
Page 81 and 82:
This Decision relates to end-produc
Page 83 and 84:
Article 5communication of informati
Page 85 and 86:
possible consequences of control me
Page 87 and 88:
Convention on Psychotropic Substanc
Page 89 and 90:
achievements of the system created
Page 91 and 92:
How to obtain EU publicationsOur pr
show all

Risk assessment of new psychoactive substances - EMCDDA - Europa

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?